Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2013-07-31
2015-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Volunteers will be healthy participants who are anesthetized with commonly used anesthetic drugs as well as a non-anesthetized group to control for circadian influences. A total of 60 subjects will be recruited for this study. All subjects (male and female) will perform basic tests for cognition on a laptop computer at 30-minute intervals during this study. The testing battery to be administered was assembled to assess multiple cognitive functions in order to determine whether and how cognitive processes return to baseline function. Electroencephalogram (measuring brain electrical activity) data will be monitored and recorded during both anesthesia and cognitive testing, for subsequent analysis.
This study is significant because it could lead to a better understanding of the neural correlates of human consciousness, as well as normal and abnormal conscious state transitions (including barriers to such transitions).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroimaging of Anesthetic Modulation of Human Consciousness
NCT03361605
Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers
NCT02149927
Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions
NCT01974427
Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex
NCT00024908
Anesthesia and Functional Connectivity: An Analysis of fMRI Changes
NCT02196259
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group: Cognitive Testing
Control arm will receive cognitive testing only without undergoing general anesthesia
Control Group: Cognitive Testing
The control group will undergo cognitive testing while connected to an EEG machine following a comparable rest period, but will not receive general anesthesia.
ISOFLURANE- Experimental Arm
Experimental arm will receive cognitive testing before and after general anesthesia
ISOFLURANE- Experimental Arm
The experimental group will be given the anesthetic isoflurane for three hours, and will undergo cognitive tests immediately following emergence from general anesthesia while connected to an EEG machine.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ISOFLURANE- Experimental Arm
The experimental group will be given the anesthetic isoflurane for three hours, and will undergo cognitive tests immediately following emergence from general anesthesia while connected to an EEG machine.
Control Group: Cognitive Testing
The control group will undergo cognitive testing while connected to an EEG machine following a comparable rest period, but will not receive general anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists Physical Status I or II (i.e., healthy),
* Body mass index \< 30 kg/m2,
* Easily visualized uvula,
* With anticipated equal recruitment of males and females.
Exclusion Criteria
* History of obstructive sleep apnea,
* Reactive airway disease,
* Neuropsychiatric disorders,
* History or current use of psychotropic medications,
* Current tobacco and alcohol use,
* History of hypertension or current medication for blood pressure control, cardiovascular disease or arrhythmias,
* Positive urine toxicology screen,
* History of reflux,
* Pregnancy,
* Family history of problems with anesthesia (including but not limited to malignant hyperthermia),
* Sleep disorders,
* History of postoperative nausea/vomiting or motion sickness,
* Allergy to eggs, egg products or soy.
20 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Washington University School of Medicine
OTHER
James S McDonnell Foundation
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
George Mashour
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
George A Mashour, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Michael Avidan, MBBCh
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Max Kelz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Mathias Basner, MD, PhD, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Washington University in St. Louis
St Louis, Missouri, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mashour GA, Palanca BJ, Basner M, Li D, Wang W, Blain-Moraes S, Lin N, Maier K, Muench M, Tarnal V, Vanini G, Ochroch EA, Hogg R, Schwartz M, Maybrier H, Hardie R, Janke E, Golmirzaie G, Picton P, McKinstry-Wu AR, Avidan MS, Kelz MB. Recovery of consciousness and cognition after general anesthesia in humans. Elife. 2021 May 10;10:e59525. doi: 10.7554/eLife.59525.
Labonte AK, Kafashan M, Huels ER, Blain-Moraes S, Basner M, Kelz MB, Mashour GA, Avidan MS, Palanca BJA; ReCCognition Study Group. The posterior dominant rhythm: an electroencephalographic biomarker for cognitive recovery after general anaesthesia. Br J Anaesth. 2023 Feb;130(2):e233-e242. doi: 10.1016/j.bja.2022.01.019. Epub 2022 Feb 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
McDonnell RCC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.